JPRN-UMIN000048834已完成未知
Effects of SGLT2 inhibitor on gut microbiota in the patients with type 2 diabetes - Effects of SGLT2 inhibitor on gut microbiota in the patients with type 2 diabetes
Akishima Clinic0 个研究点目标入组 8 人开始时间: 2022年9月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •eGFR: less than 45 mL/min/1.73 m2
研究者
相似试验
已完成
不适用
Effects of treatment with SGLT2 inhibitor on the initiation of continuous positive airway pressure therapy in type 2 diabetic patients with obstructive sleep apnea syndromeType 2 diabetesJPRN-UMIN000045226Akishima Clinic16
尚未招募
2 期
Mechanisms of action of SGLT2 inhibitors in patients with heart failure with reduced ejection fraction (HFrEF)Heart Failure with Reduced Ejection fractionCardiovascular - Other cardiovascular diseasesACTRN12621000187842The Alfred Hospital36
尚未招募
Unknown
Observational Study of the effect of SGLT2 inhibitor on Glycemic Control Indicesdiabetes mellitusJPRN-UMIN000050228agoya University4,250
招募中
不适用
Influence of SGLT2 inhibitor on myocardial fatty acid metabolismtype 2 diabetesJPRN-jRCT1041190002Kumazaki Setsuo40
已完成
不适用
Investigation of metabolic change by SGLT2 inhibitors in type 2 diabetes patients.JPRN-UMIN000015057Kitasato University School of Medicine,Endocrinology and Metabolism.20